Advertisement
News
Subscribe to MDT Magazine News

Summary Information for: MEL 80? Excimer Laser System

April 25, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for MEL 80? Excimer Laser System (P060004S001).

TOPICS:

Boston Scientific gets FDA for ION stent system

April 25, 2011 7:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Continuing a spring fling of stent approvals, Boston Scientific Corp. today announced that it had won approval from the FDA for its ION drug-eluting coronary stent.

Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer

April 25, 2011 7:36 am | by Bio-Medicine.Org | Comments

NEW YORK, April 25, 2011 /- Accuracy in radiation therapy demands careful targeting and patient positioning – precision measured in millimeters. The Farber Center for Radiation Oncology , the first and only freestanding cancer center of its kind in Manhattan, is among the first...

TOPICS:
Advertisement

Pharmacists Offer Guidance on Top Over-The-Counter Medications

April 25, 2011 7:33 am | by Bio-Medicine.Org | Comments

WASHINGTON, April 25, 2011 /PRNewswire-USNewswire/ -- The 2010 Pharmacy Today Over-the-Counter Product Survey , conducted by the American Pharmacists Association , reveals pharmacists believe that 81% of consumers purchase the over-the-counter (OTC) product that was recommended by their...

TOPICS:

Idenix attracts $5M equity financing

April 25, 2011 6:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Idenix Pharmaceuticals Inc., a Cambridge developer of human viral disease therapeutics, has taken in $5 million in equity fundraising, according to a filing with the U.S. Securities and Exchange Commission.

Columbus Energy Limited Hires Grenfell Consulting Ltd. as Investor Relations Advisor

April 25, 2011 5:45 am | by The Associated Press | Comments

Columbus Energy Limited (TSX VENTURE: CEL) is pleased to announce that it has hired Grenfell Consulting Ltd. of London, England as its Investor Relations Advisor.The range of activity that Grenfell Consulting Ltd. undertakes includes preparing executives for presentations, writing and...

CryoLife Launches BioGlue® Surgical Adhesive in Japan

April 25, 2011 5:36 am | by Bio-Medicine.Org | Comments

ATLANTA, April 25, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011. BioGlue...

TOPICS:

ConvaTec Healthcare Announces 2010 Year-End Earnings Call

April 25, 2011 5:36 am | by Bio-Medicine.Org | Comments

SKILLMAN, N.J., April 25, 2011 /- ConvaTec Healthcare today announced that it will report its 2010 year-end earnings on Thursday, April 28, 2011. David Johnson, CEO and George Kegler, CFO will host an analyst and investor call at 9:00 AM EDT live via telephone. Questions and answers will...

TOPICS:
Advertisement

Ferring Celebrates Winners of 2010 My Little Miracle Essay Contest During National Infertility Awareness Week

April 25, 2011 5:34 am | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J., April 25, 2011 /- Celebrating National Infertility Awareness Week, April 24-30, 2011, Ferring Pharmaceuticals Inc. is honoring three lucky families who won its 2010 My Little Miracle Essay Contest for their inspirational stories about overcoming their struggle with...

TOPICS:

Mylan Launches First Generic Version of Femara® Tablets

April 25, 2011 5:33 am | by Bio-Medicine.Org | Comments

PITTSBURGH, April 25, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a...

TOPICS:

Thomas Mac Mahon Joins SynapDx Corporation's Board of Directors

April 25, 2011 5:32 am | by Bio-Medicine.Org | Comments

SOUTHBOROUGH, Mass., April 25, 2011 /- SynapDx Corporation announced today that Thomas Mac Mahon has joined its board of directors. Thomas Mac Mahon was President and Chief Executive Officer and a member of the Executive and Management Committees of Laboratory Corporation of America...

TOPICS:

Volcano Corporation Schedules First Quarter Conference Call, Webcast

April 25, 2011 5:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 25, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its...

TOPICS:

Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Topical Oxygen Chamber for Extremities

April 25, 2011 5:30 am | by U.S. Food & Drug Administration | Comments

Topics: Oxygen Chambers

TOPICS:

Earnings Preview: WellPoint to report 1Q results

April 25, 2011 4:45 am | by The Associated Press | Comments

WellPoint Inc., the largest U.S. health insurer based on membership, reports first-quarter results Wednesday before the market opens.WHAT TO WATCH FOR: Many health insurance investors breathed a sigh of relief April 21 when UnitedHealth Group Inc. reported a 13 percent jump in first-quarter...

TomoTherapy Enters Into Radiation Therapy Equipment Purchasing Agreement With ROi

April 25, 2011 4:45 am | by The Associated Press | Comments

http://www.tomotherapy.com () —TomoTherapy Incorporated (http://www.tomotherapy.com) (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that it has signed a radiation therapy equipment purchasing agreement with...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading